• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种建立 Epstein-Barr 病毒相关 NK/T 细胞淋巴瘤小鼠模型的方法。

One method to establish Epstein-Barr virus-associated NK/T cell lymphoma mouse models.

机构信息

Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Henan Jonint International Research Laboratory of Lymphoma, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

J Cell Mol Med. 2019 Feb;23(2):1509-1516. doi: 10.1111/jcmm.14057. Epub 2018 Nov 28.

DOI:10.1111/jcmm.14057
PMID:30484952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349153/
Abstract

Novel nude mice model of human NK/T cell lymphoma were established by subcutaneously injecting two NK/T cell lymphoma cell lines into the right axillary region of mice and successful passages were completed by injecting cell suspension which was obtained through a 70-μm cell strainer. These mice models and corresponding cell clones have been successfully developed for more than 8 generations. The survival rates of both resuscitation and transplantation in NKYS and YT models were 90% and 70% correspondingly. Pathologically, the tumour cells in all passages of the lymphoma-bearing mice and cell lines obtained from tumours were parallel to initial cell lines. Immunologically, the tumour cells expressed the characteristics of the primary and essential NK/T lymphomas. The novel mice models maintained the essential features of human NK/T cell lymphoma, and they would be ideal tools in vivo for further research of human NK/T cell lymphoma.

摘要

建立了人 NK/T 细胞淋巴瘤裸鼠模型,将两种 NK/T 细胞淋巴瘤细胞系皮下注射到裸鼠右侧腋窝,通过 70μm 细胞筛获得细胞悬液,成功传代 8 代以上。这些小鼠模型和相应的细胞克隆已成功开发超过 8 代。NKYS 和 YT 模型的复苏和移植存活率分别为 90%和 70%。从肿瘤中获得的肿瘤细胞和细胞系在所有传代中均与初始细胞系平行。免疫上,肿瘤细胞表达了原发性和基本 NK/T 淋巴瘤的特征。新型小鼠模型保持了人 NK/T 细胞淋巴瘤的基本特征,它们将成为人类 NK/T 细胞淋巴瘤体内研究的理想工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/853108d8baf4/JCMM-23-1509-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/bf556db1ee49/JCMM-23-1509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/fd07d7471f50/JCMM-23-1509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/0081bc08c37c/JCMM-23-1509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/71f18a6f4f9d/JCMM-23-1509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/d2436daa6ca9/JCMM-23-1509-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/b80138ca98f1/JCMM-23-1509-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/a21599b46b7a/JCMM-23-1509-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/853108d8baf4/JCMM-23-1509-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/bf556db1ee49/JCMM-23-1509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/fd07d7471f50/JCMM-23-1509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/0081bc08c37c/JCMM-23-1509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/71f18a6f4f9d/JCMM-23-1509-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/d2436daa6ca9/JCMM-23-1509-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/b80138ca98f1/JCMM-23-1509-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/a21599b46b7a/JCMM-23-1509-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8179/6349153/853108d8baf4/JCMM-23-1509-g008.jpg

相似文献

1
One method to establish Epstein-Barr virus-associated NK/T cell lymphoma mouse models.一种建立 Epstein-Barr 病毒相关 NK/T 细胞淋巴瘤小鼠模型的方法。
J Cell Mol Med. 2019 Feb;23(2):1509-1516. doi: 10.1111/jcmm.14057. Epub 2018 Nov 28.
2
CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.中国南方一家机构622例成熟T细胞和自然杀伤细胞淋巴瘤中鼻型结外自然杀伤/T细胞淋巴瘤的CD30表达情况。
Chin J Cancer. 2017 May 10;36(1):43. doi: 10.1186/s40880-017-0212-9.
3
Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis.结外 NK/T 细胞淋巴瘤:自然杀伤细胞和 EBV 在淋巴瘤发生中的作用。
Int J Mol Sci. 2020 Feb 22;21(4):1501. doi: 10.3390/ijms21041501.
4
Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma.EB 病毒编码的 miR-BART20-5p 通过对 p53 的二次抑制来抑制侵袭性鼻 NK/T 细胞淋巴瘤中的 T-bet 翻译。
Am J Pathol. 2013 May;182(5):1865-75. doi: 10.1016/j.ajpath.2013.01.025.
5
A novel nude mice model of human extranodal nasal type NK/T-cell lymphoma.一种新型的人结外鼻型NK/T细胞淋巴瘤裸鼠模型。
Leukemia. 2008 Jan;22(1):170-8. doi: 10.1038/sj.leu.2404945. Epub 2007 Sep 13.
6
Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.爱泼斯坦-巴尔病毒阳性的淋巴结T/NK细胞淋巴瘤:15例具有独特临床病理特征的病例分析
Hum Pathol. 2015 Jul;46(7):981-90. doi: 10.1016/j.humpath.2015.03.002. Epub 2015 Mar 25.
7
Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.从结外 NK/T 细胞淋巴瘤,鼻型中分离的 Epstein-Barr 病毒的全基因组分析。
Oncologist. 2019 Sep;24(9):e905-e913. doi: 10.1634/theoncologist.2017-0588. Epub 2019 Apr 2.
8
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.一种新型潜伏膜蛋白 2 转录本在 EBV 阳性 NK/T 细胞淋巴组织增生性疾病中表达,编码细胞免疫治疗的靶标。
Blood. 2010 Nov 11;116(19):3695-704. doi: 10.1182/blood-2010-06-292268. Epub 2010 Jul 29.
9
Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.丁酸钠对 EBV 相关 T/NK 细胞淋巴瘤的抗肿瘤作用。
Cancer Sci. 2014 Jun;105(6):713-22. doi: 10.1111/cas.12418. Epub 2014 May 13.
10
MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.通过深度测序对 Epstein-Barr 病毒相关 NK/T 细胞淋巴瘤进行 microRNA 分析。
PLoS One. 2012;7(8):e42193. doi: 10.1371/journal.pone.0042193. Epub 2012 Aug 3.

引用本文的文献

1
Corrigendum.勘误
J Cell Mol Med. 2023 Jun;27(12):1761-1762. doi: 10.1111/jcmm.17775.
2
Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells.STAT3 和 TP53 突变恶性 NK 细胞中的选择性药物组合弱点。
Blood Adv. 2021 Apr 13;5(7):1862-1875. doi: 10.1182/bloodadvances.2020003300.
3
Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma.单核细胞上PD-L1的表达是自然杀伤/T细胞淋巴瘤预后的新型预测指标。

本文引用的文献

1
The diagnosis and management of NK/T-cell lymphomas.NK/T细胞淋巴瘤的诊断与管理
J Hematol Oncol. 2017 Apr 14;10(1):85. doi: 10.1186/s13045-017-0452-9.
2
Efficient Regeneration of Human Vα24 Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo.人Vα24不变自然杀伤T细胞的高效再生及其体内抗肿瘤活性
Stem Cells. 2016 Dec;34(12):2852-2860. doi: 10.1002/stem.2465. Epub 2016 Aug 1.
3
MicroRNA-204 targets signal transducer and activator of transcription 5 expression and inhibits proliferation of B-cell lymphoma cells.
Front Oncol. 2020 Aug 6;10:1360. doi: 10.3389/fonc.2020.01360. eCollection 2020.
微小RNA-204靶向信号转导及转录激活因子5的表达并抑制B细胞淋巴瘤细胞的增殖。
Mol Med Rep. 2015 Jun;11(6):4567-72. doi: 10.3892/mmr.2015.3298. Epub 2015 Feb 4.
4
mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.mTOR 抑制剂诱导细胞周期停滞并抑制 Epstein-Barr 病毒相关 T 和自然杀伤细胞淋巴瘤细胞的肿瘤生长。
Clin Cancer Res. 2014 Nov 1;20(21):5412-22. doi: 10.1158/1078-0432.CCR-13-3172. Epub 2014 Sep 10.
5
Immunomodulation and lymphoma in humans.免疫调节与人类淋巴瘤。
J Immunotoxicol. 2014 Jan-Mar;11(1):1-12. doi: 10.3109/1547691X.2013.798388. Epub 2013 Jun 7.
6
In vivo serial selection of human pancreatic cancer cells in orthotopic mouse models produces high metastatic variants irrespective of Kras status.在原位小鼠模型中对人胰腺癌细胞进行体内连续选择,产生高转移变体,而与 Kras 状态无关。
J Surg Res. 2013 Sep;184(1):290-8. doi: 10.1016/j.jss.2013.03.049. Epub 2013 Apr 5.
7
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group.SMILE 方案治疗自然杀伤/T 细胞淋巴瘤的疗效和安全性:亚洲淋巴瘤研究组的分析。
Blood. 2012 Oct 11;120(15):2973-80. doi: 10.1182/blood-2012-05-431460. Epub 2012 Aug 23.
8
Issues to be considered when studying cancer in vitro.研究体外癌症时需要考虑的问题。
Crit Rev Oncol Hematol. 2013 Feb;85(2):95-111. doi: 10.1016/j.critrevonc.2012.06.007. Epub 2012 Jul 21.
9
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
10
Mouse models of advanced spontaneous metastasis for experimental therapeutics.用于实验治疗的晚期自发性转移的小鼠模型。
Nat Rev Cancer. 2011 Feb;11(2):135-41. doi: 10.1038/nrc3001.